Commentary on Phase 3 Study of OnabotulinumtoxinA Distributed Between Frontalis, Glabellar Complex, and Lateral Canthal Areas for Treatment of Upper Facial Lines-Reference-Cited by-同舟云学术

Commentary on Phase 3 Study of OnabotulinumtoxinA Distributed Between Frontalis, Glabellar Complex, and Lateral Canthal Areas for Treatment of Upper Facial Lines

Published:2019-04 Issue:4 Volume:45 Page:598-599
ISSN:1076-0512
Container-title:Dermatologic Surgery
language:en
Short-container-title:DS

Author:

Minokadeh Ardalan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Dermatology,General Medicine,Surgery

Reference10 articles.

1. Phase 3 study of OnabotulinumtoxinA distributed between frontalis, glabellar complex, and lateral canthal lines for treatment of upper facial lines;De Boulle;Dermatol Surg,2018

2. Efficacy and safety of OnabotulinumtoxinA treatment of forehead lines: a multicenter, randomized, dose-ranging controlled trial;Solish;Dermatol Surg,2016

3. Forehead line treatment with OnabotulinumtoxinA in subjects with forehead and glabellar facial rhytids: a phase 3 study;Fagien;Dermatol Surg,2017

4. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines;Carruthers;J Am Acad Dermatol,2002

5. Efficacy and safety of OnabotulinumtoxinA for the treatment of crows feet lines: a multicenter, randomized, controlled trial;Carruthers;Dermatol Surg,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuromodulators in Men;Dermatologic Surgery;2024-07-18

2. Forehead Movement Discrepancies After Botulinum Toxin Injections: A Review of Etiology, Correction, and Prevention;Dermatologic Surgery;2021-09-02

3. Commentary on Efficacy, Patient-Reported Outcomes, and Safety for Millennial Subjects Treated With OnabotulinumtoxinA for Moderate to Severe Horizontal Forehead Lines;Dermatologic Surgery;2019-10-12